title: [FDG-PET in the staging of malignant melanoma].
abstract: Positron emission tomography (PET scanning) is a useful tool in staging of malignant melanoma. A radiolabelled glucoseanalogue can demonstrate changes in metabolism and thus identify malignancy in macroscopic unchanged structures. It is a non-invasive, fast method to identify especially visceral, still symptomless metastases. The patient can often be spared from mutilating surgery.
authors.affiliation: Afdeling for klinisk fysiologi & nuklearmedicin, Rigshospitalet, København.
authors.forename: A
authors.initials: A
authors.lastname: Eigtved
mesh_terms: D003287:Contrast Media; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008545:Melanoma / Q000175:diagnosis* / Q000473:pathology; D009367:Neoplasm Staging; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed
chemical_list: D003287:Contrast Media; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
vernacular_title: FDG-PET til udredning af malignt melanom.